Drug
Nevirapine (NVP)
Nevirapine (NVP) is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_3
3
75%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 33 (75.0%)
Trials by Status
recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT02140255
completedphase_3
HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
NCT00978068
completedphase_3
A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)
NCT00144183
completedphase_3
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
NCT00099359
Clinical Trials (4)
Showing 4 of 4 trials
NCT02140255Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT00978068Phase 3
HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
NCT00144183Phase 3
A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)
NCT00099359Phase 3
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4